Pay in 4 interest-free payments of $5.55 Learn more
Ships within 48 hours · Estimated delivery Aug 5 - Aug 10
Consistency is critical with tirzepatide
The following reflects current understanding based on phase 2 data and the established safety profiles of approved GLP-1 receptor agonists per UK Summary of Product Characteristics (SmPCs)
When in doubt, replace the vial
It was originally developed by Eli Lilly as a research molecule and is widely characterized in the literature as a unitary triple receptor agonist with affinity for the glucagon-like peptide-1 receptor (GLP-1R), the GIP receptor (GIPR), and the glucagon receptor (GCGR)
Researchers should factor in the total cost of peptide therapy including reconstitution supplies , syringes, and storage equipment
US$ 20.13
US$ 20.59
US$ 28.00
US$ 22.60
US$ 28.61
US$ 21.75
